Clinical Trial Update: Mometasone and Markers of Airway Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating mometasone for markers of airway inflammation in asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• mometasone (mometasone)

Snippet

Sponsor: Creighton University | Conditions: Asthma | Phase 4 | Status: COMPLETED